O'Keefe Kathryn L, Kilic Ahmet, Pope-Harman Amy, Hayes Don, Kirkby Stephen, Higgins Robert S D, Whitson Bryan A
Department of Surgery, Division of Cardiac Surgery, Wexner Medical Center, Ohio State University, OH, USA.
Exp Clin Transplant. 2014 Aug;12(4):283-9.
Pulmonary hypertension and right ventricular dysfunction can complicate lung transplant. Pulmonary artery pressures affect outcome are uncertain during wait list. We evaluated changes in wait list pulmonary artery pressures on survival after lung transplant.
We queried the United Network for Organ Sharing/Standard Transplant Analysis and Research registry from 1987 to 2012 for all lung transplants. Recipients with unique pulmonary artery pressure measurements upon listing and transplant were included. Mean pulmonary artery pressure was rated as increased (increase > 5 mm Hg), decreased (decrease > 5 mm Hg), or unchanged (variation < 5 mm Hg).
There were 23 951 lung transplants and 1677 recipients were included. Diagnoses demonstrated significant changes in mean pulmonary artery pressure during the listing period (P ≤ .0001). In recipients with chronic obstructive pulmonary disease, survival was poorer when mean pulmonary artery pressure was increased than decreased (P ≤ .03). In recipients with primary pulmonary hypertension, survival was poorer when mean pulmonary artery pressure was decreased than increased (P ≤ .02). Proportional hazards analysis showed that increases in mean pulmonary artery pressure independently affected survival (hazard ratio, 0.78; 95% confidence interval, 0.62-0.96).
Although the mechanism is unknown, an increase in mean pulmonary artery pressure in patients with chronic obstructive pulmonary disease is associated with poorer survival after lung transplant. In contrast, patients with primary pulmonary hypertension with decreased mean pulmonary artery pressure have poorer survival after lung transplant. In patients with primary pulmonary hypertension, changes in pulmonary artery pressure may be a surrogate for a failing right ventricular function. In chronic obstructive pulmonary disease, the change in pressure suggests an undetermined progressive process. Further study of right ventricular function is warranted to determine the effects of changes in pulmonary artery pressure on lung transplant recipients.
肺动脉高压和右心室功能障碍会使肺移植变得复杂。在等待移植名单期间,肺动脉压力对预后的影响尚不确定。我们评估了等待移植名单上肺动脉压力的变化对肺移植后生存情况的影响。
我们查询了1987年至2012年器官共享联合网络/标准移植分析与研究登记处的所有肺移植病例。纳入了在登记和移植时进行了独特肺动脉压力测量的受者。平均肺动脉压力被评定为升高(升高>5mmHg)、降低(降低>5mmHg)或不变(变化<5mmHg)。
共有23951例肺移植,纳入了1677名受者。诊断显示在登记期间平均肺动脉压力有显著变化(P≤.0001)。在慢性阻塞性肺疾病患者中,平均肺动脉压力升高时的生存率低于降低时(P≤.03)。在原发性肺动脉高压患者中,平均肺动脉压力降低时的生存率低于升高时(P≤.02)。比例风险分析表明,平均肺动脉压力的升高独立影响生存(风险比,0.78;95%置信区间,0.62 - 0.96)。
虽然机制尚不清楚,但慢性阻塞性肺疾病患者平均肺动脉压力升高与肺移植后较差的生存率相关。相反,原发性肺动脉高压患者平均肺动脉压力降低时肺移植后的生存率较差。在原发性肺动脉高压患者中,肺动脉压力的变化可能是右心室功能衰竭的一个替代指标。在慢性阻塞性肺疾病中,压力变化提示一个未确定的进展过程。有必要进一步研究右心室功能,以确定肺动脉压力变化对肺移植受者的影响。